Page last updated: 2024-08-25

drospirenone and Premenstrual Dysphoric Disorder

drospirenone has been researched along with Premenstrual Dysphoric Disorder in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ma, S; Song, SJ1
Cheng, W; Fu, Y; Li, L; Mi, W; Sun, L; Wang, J; Xie, S; Zhang, H; Zhang, J1

Reviews

1 review(s) available for drospirenone and Premenstrual Dysphoric Disorder

ArticleYear
Oral contraceptives containing drospirenone for premenstrual syndrome.
    The Cochrane database of systematic reviews, 2023, 06-23, Volume: 6

    Topics: Contraceptives, Oral, Combined; Drug-Related Side Effects and Adverse Reactions; Estrogens; Female; Humans; Premenstrual Dysphoric Disorder; Premenstrual Syndrome; Progestins

2023

Trials

1 trial(s) available for drospirenone and Premenstrual Dysphoric Disorder

ArticleYear
[Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in the treatment of premenstrual dysphoric disorder: a randomized, double blind placebo-controlled study].
    Zhonghua fu chan ke za zhi, 2014, Volume: 49, Issue:7

    Topics: Androstenes; Contraceptives, Oral; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Menorrhagia; Metrorrhagia; Premenstrual Dysphoric Disorder; Premenstrual Syndrome; Safety; Severity of Illness Index; Treatment Outcome

2014